Antiadrenergic Therapy of Chronic Heart Failure

This publication has 14 references indexed in Scilit:

• Synergistic Polymorphisms of β₁- and α_2C-Adrenergic Receptors and the Risk of Congestive Heart Failure
  New England Journal of Medicine, 2002
• Effects of Sustained-Release Moxonidine, an Imidazoline Agonist, on Plasma Norepinephrine in Patients With Chronic Heart Failure
  Circulation, 2002
• Inotropes and β-blockers: Is there a need for new guidelines?
  Journal of Cardiac Failure, 2001
• Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium
  British Journal of Pharmacology, 2001
• A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
  New England Journal of Medicine, 2001
• Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium
  British Journal of Pharmacology, 2000
• Heart failure 99 — the Moxcon story
  International Journal of Cardiology, 1999
• The role of third-generation beta-blocking agents in chronic heart failure
  Clinical Cardiology, 1998
• Xamoterol in severe heart failure
  The Lancet, 1990
• Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure
  The American Journal of Medicine, 1963